Combination of CM082 With JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC) Who Progressed on First-line Treatment: a Phase II Study
Latest Information Update: 07 Jul 2022
At a glance
- Drugs Toripalimab (Primary) ; Vorolanib (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Sponsors AnewPharma
Most Recent Events
- 07 Jul 2020 Planned End Date changed from 30 Jun 2020 to 31 Dec 2021.
- 07 Jul 2020 Planned primary completion date changed from 25 Jan 2020 to 30 Jun 2021.
- 07 Jul 2020 Status changed from not yet recruiting to recruiting.